Serum Tenascin-C and Alarin Levels Are Associated with Cardiovascular Diseases in Type 2 Diabetes Mellitus

Table 2

Comparison of the medications between CVD groups and non-CVD group.

Medications	CVD	Non-CVD	value
Antihypertension drugs	(n = 69)	(n = 57)
β-blockers	33.33	21.00	0.126
Diuretics	30.43	10.53	0.007
Calcium-channel blockers	49.28	50.88	0.858
RAAS inhibitors	68.12	43.86	0.006
Others	7.25	8.77	0.753
Lipid-lowering drugs	(n = 67)	(n = 59)
Statins	98.51	89.83	0.034
Fibrates	1.49	6.78	0.129
Antidiabetic drugs	(n = 95)	(n = 155)
Diet	2.11	1.29	0.618
Oral drugs	76.84	67.74	0.123
Insulin	49.47	28.39	0.001

Data are percentage unless otherwise indicated. CVD, cardiovascular diseases; RAAS, renin–angiotensin–aldosterone system.